Probe of US generic drug ‘cartel’ grows to 16 companies, 47 states

What began as a lawsuit over the prices of two drugs has grown to become a 47-state case involving at least 16 generic drug companies and 300 drugs, according to The Boston Globe.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.